Healthcare

According to a market report by Lucintel, the future of the cell based assay market looks promising with opportunities in pharmaceutical & biopharmaceutical companies, CROs, and academic & research institutes. The global cell based assay market is expected to reach an estimated $32.3 billion by 2028 with a CAGR of 8.5% from 2023 to 2028. The major drivers for this market are increasing incidences of chronic diseases, increasing preference for cell-based assay, and rising investment in R&D of drug discovery activities.



In this market, drug discovery and basic research are the major type segments. Lucintel forecasts that drug discovery segment is expected to witness the highest growth over the forecast period due to growing demand for novel therapeutic drugs to treat chronic diseases and increasing investment in research and development activities by the biopharmaceutical companies.



Within this market, pharmaceutical and biopharmaceutical companies are expected to witness the highest growth over the forecast period due to increasing number of drug discovery projects and growing R&D expenditure by various biotech and pharma companies to develop drug candidates.



APAC is expected to witness the highest growth over the forecast period due to the existence of private as well as government funding for research and development, rising demand for drug development, and increasing infrastructural development across the region.



Thermo Fisher Scientific, Danaher Corporation, Becton, Dickinson and Company, GE Healthcare, Merck KGaA, Lonza Group PerkinElmer, Charles River Laboratories, Cell Signaling Technologies, Cisbio, Cell Biolabs, and Promega Corporation are the major suppliers in the global cell based assay market.



Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global cell based assay market by type, product & service, end user industry, and region. Lucintel has compiled a comprehensive research report titled “Growth Opportunities in the Global Cell Based Assay Market 2023-2028: Trends, Forecast, and Opportunity Analysis.” The Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global cell based assay market by type, product & service, end user industry, and region, as follows:

This more than 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or email us at helpdesk@lucintel.com.

 

Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. Lucintel offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.

 

Q.1. What are some of the most promising, high-growth opportunities for the global cell based assay market by type (drug discovery (toxicity studies, pharmacodynamic studies, and pharmacokinetic studies), basic research, and other applications), product & service (consumables, (reagents, and assay kits (reporter gene assays, cell growth assays, second messenger assays, cell death assays, and other assay kits)), cell lines (immortalized cell lines, primary cell lines, and stem cell lines), microplates, probes & labels, other consumables, instruments & software, services), end user industry (pharmaceutical & biopharmaceutical companies, CROs, and academic & research institutes), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or type substitution?

Q.11. What M&A activity did occur in the last five years and how did they impact the industry